PCVX ▼ -0.9% - Vaxcyte, Inc.
$PCVX Vaxcyte: Prices $500M Equity Offering at $64 per Share and $500M Convertible Notes Offering ? • Equity offering includes 7.41M shares plus pre-funded warrants for 400,000 shares; underwriters have an option for up to 1.17M additional shares. • Convertible notes carry 1.50% interest, mature in 2032 and initially convert at ~$89.60 per share, a 40% premium to the equity offering price. • Offerings are expected to close Oct. 9, with proceeds supporting VAX-31 development, manufacturing expansion, inventory and potential U.S. launch preparations.
07-OCT-2026 05:21 AM ET
Share this post
More filings for $PCVX
PCVX - Vaxcyte, Inc. - SEC Filing Update (06-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 6, 2026PCVX ▲ +7.9% - Vaxcyte, Inc.Nov 4, 2026PCVX ▲ +7.9% - Vaxcyte, Inc.Nov 4, 2026PCVX ▲ +9.4% - Vaxcyte, Inc.Oct 10, 2026PCVX ▼ -9.8% - Vaxcyte, Inc.Oct 7, 2026PCVX ▲ +27.3% - Vaxcyte, Inc.Oct 5, 2026
View full $PCVX filing history →💬 Comments
Loading comments…
Leave a comment
